Evidence map›Paper›PMID 29992027›Full record

ArticleNew microbes and new infections2018

Noncontiguous finished genome sequences and descriptions of

M D Mbogning Fonkou, M Mailhe, S Ndongo, D Ricaboni, A Morand, F Cornu, M Tidjani Alou, M Bilen, C Andrieu, A Levasseur and 2 more

RetractedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

M D Mbogning FonkouAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
M MailheAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
S NdongoAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
D RicaboniAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
A MorandAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
F CornuAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
M Tidjani AlouAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
M BilenAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
C AndrieuAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
A LevasseurAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
F CadoretAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
D RaoultAix Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The taxonogenomic approach, including the culturomics techniques, is now currently used to isolate and characterize new bacteria. These approaches notably allowed us to discover six new species of the

Indexed as

CulturomicsHuman gut microbiotaHuman lung microbiotaNew speciesTaxonogenomics

Identifiers

PMID29992027
PMCPMC6036942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.